title: [Electrolyte disorders in preeclampsia. A case report].
abstract: The occurrence of electrolyte disorders as hypocalcemia and/or hyponatremia is an uncommon event in preeclampsia, which can be the sign of serious situation, with potentially unfavourable consequences for the mother and her fœtus. Hyponatremia in the setting of preeclampsia is an indicator of severity, and requires the understanding of the etiologic mechanisms to initiate an appropriate treatment. Indeed the often-considered fluid restriction is rarely a treatment option for pregnant women. Hypocalcemia is a complication that must be monitored when a treatment with high doses of intravenous magnesium sulphate is introduced. In this context, hypocalcemia must be sought, with the exclusion of other etiologies as vitamin D deficiency, hypoparathyroidism or renal and extrarenal loss of calcium. A replacement therapy, intravenous or oral according to circumstances, should be considered in case of severe or symptomatic hypocalcemia.
authors.affiliation: Département de gynécologie, obstétrique et génétique, centre hospitalier universitaire Vaudois, avenue Pierre-Decker 2, 1011 Lausanne, Suisse. Electronic address: pauline.bodenmann@gmail.com.
authors.forename: Pauline
authors.initials: P
authors.lastname: Bodenmann Gobin
authors.affiliation: Service de néphrologie et consultation d'hypertension, département de médecine, centre hospitalier universitaire Vaudois, rue du Bugnon 17, 1005 Lausanne, Suisse.
authors.forename: Niels
authors.initials: N
authors.lastname: Gobin
authors.affiliation: Service d'endocrinologie, diabétologie et métabolisme, département de médecine interne, centre hospitalier universitaire Vaudois, bâtiment hospitalier, rue du Bugnon 46, 1011 Lausanne, Suisse.
authors.forename: Julien
authors.initials: J
authors.lastname: Ducry
authors.affiliation: Service d'endocrinologie, diabétologie et métabolisme, département de médecine interne, centre hospitalier universitaire Vaudois, bâtiment hospitalier, rue du Bugnon 46, 1011 Lausanne, Suisse.
authors.forename: Luc
authors.initials: L
authors.lastname: Portmann
authors.affiliation: Département de gynécologie, obstétrique et génétique, centre hospitalier universitaire Vaudois, avenue Pierre-Decker 2, 1011 Lausanne, Suisse.
authors.forename: Yvan
authors.initials: Y
authors.lastname: Vial
authors.affiliation: Service de néphrologie et consultation d'hypertension, département de médecine, centre hospitalier universitaire Vaudois, rue du Bugnon 17, 1005 Lausanne, Suisse.
authors.forename: Bruno
authors.initials: B
authors.lastname: Vogt
mesh_terms: D000328:Adult; D000450:Aldosterone / Q000502:physiology; D000959:Antihypertensive Agents / Q000008:administration & dosage / Q000627:therapeutic use; D019559:Capillary Leak Syndrome / Q000209:etiology / Q000503:physiopathology; D002585:Cesarean Section; D004630:Emergencies; D005260:Female; D005307:Fertilization in Vitro; D005317:Fetal Growth Retardation / Q000209:etiology; D006801:Humans; D006996:Hypocalcemia / Q000188:drug therapy / Q000209:etiology* / Q000503:physiopathology; D007010:Hyponatremia / Q000188:drug therapy / Q000209:etiology* / Q000503:physiopathology; D007231:Infant, Newborn; D007262:Infusions, Intravenous; D007741:Labetalol / Q000008:administration & dosage / Q000627:therapeutic use; D008278:Magnesium Sulfate / Q000008:administration & dosage / Q000627:therapeutic use; D008297:Male; D011225:Pre-Eclampsia / Q000097:blood* / Q000503:physiopathology; D011247:Pregnancy; D011311:Pressoreceptors / Q000502:physiology; D012084:Renin-Angiotensin System / Q000502:physiology; D014667:Vasopressins / Q000378:metabolism
chemical_list: D000959:Antihypertensive Agents; D014667:Vasopressins; D000450:Aldosterone; D008278:Magnesium Sulfate; D007741:Labetalol
keywords: Hypocalcemia; Hypocalcémie; Hyponatremia; Hyponatrémie; Magnesium sulfate; Preeclampsia; Pré-éclampsie; Sulfate de magnésium